Magnetic field exposure assessment in a case-control study of childhood leukemia.
Epidemiologic evaluation of the relation between magnetic field exposures and cancer depends critically on study design, particularly the methods used for exposure assessment. We incorporated a complex magnetic field exposure assessment protocol into a large incident case-control study of childhood leukemia. We measured residential magnetic fields using a standard protocol in current and former homes of 638 cases and 620 controls and determined wire codes for 414 case-control pairs. We chose a time-weighted average of magnetic field measurements in each eligible home, weighted by the time the subject lived in each home as the main exposure metric for each subject. We found that 24-hour bedroom magnetic field measurements adequately characterize children's residential exposure and that measuring other rooms contributes only slightly to the estimate of average residential exposure to magnetic fields. Front door measured fields provide useful exposure information when interior measurements are missing. If feasible, measuring multiple homes in which the subject has resided is preferable to measuring a single home. A similar distribution of wire codes for controls agreeing or refusing to participate in our study implies that risk estimates derived from wire code data will not be influenced by response bias.
Kleinerman
R A
RA
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20892-7362, USA.
Linet
M S
MS
Hatch
E E
EE
Wacholder
S
S
Tarone
R E
RE
Severson
R K
RK
Kaune
W T
WT
Friedman
D R
DR
Haines
C M
CM
Muirhead
C R
CR
Boice
J D
JD
Robison
L L
LL
D000293:Adolescent; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004559:Electric Wiring / Q000592:standards; D004574:Electromagnetic Fields / Q000009:adverse effects*; D004781:Environmental Exposure / Q000009:adverse effects*; D006798:Housing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018579:Patient Selection; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000209:etiology*; D011834:Radiation Monitoring / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D012107:Research Design; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology